What do drug monopolies cost consumers in developing countries?
Abstract: This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.
File(s): File format is text/html https://www.newyorkfed.org/medialibrary/media/research/staff_reports/sr530.html
File(s): File format is application/pdf https://www.newyorkfed.org/medialibrary/media/research/staff_reports/sr530.pdf
Provider: Federal Reserve Bank of New York
Part of Series: Staff Reports
Publication Date: 2011-12-01
Note: For a published version of this report, see Rebecca Hellerstein, "What Do Drug Monopolies Cost Consumers in Developing Countries?" Economics Letters 116, no. 1 (July 2012): 108-111.